AzTrials
AzTrials

IsthmoceleDISSUCNCT07608874

Comparing Decidual Inclusion vs. Exclusion in Uterine Suture Techniques During Cesarean Section to Improve Scar Thickness and Reduce Isthmocele Risk in Primiparous Women

A study testing Single-Layered Non-Locked Closure with Decidual Inclusion and Single-Layered Non-Locked Closure with Decidual Sparing in people with Isthmocele and Cesarean Scar Diverticula, run by Kantonsspital Baden at 1 site in Switzerland.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study compares two ways of closing the uterus during cesarean delivery. In one group, the decidual layer near the uterine cavity is included in the suture. In the other group, this layer is left out. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Isthmocele, Cesarean Scar Diverticula
What is being tested?
Single-Layered Non-Locked Closure with Decidual Inclusion and Single-Layered Non-Locked Closure with Decidual Sparing
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
374 participants
Where
1 siteSwitzerland
Study dates
17 Jun 2026to 30 May 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Singleton, term pregnancy
  • Elective cesarean section before labor onset or membrane rupture
  • Maternal age >18 years
  • Ability to provide informed consent

Who cannot join

  • Placenta previa
  • Maternal substance abuse or infection
  • Suspected placenta accreta
  • Diabetes
  • one or more prior cesarean section
  • Vulnerable participants (e.g., mental health conditions)
  • Emergency cesarean sections

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Amr S. Hamza, Assoc. Prof. contact

+41564863513

amr.hamza@ksb.ch

Leonhard Schaeffer, Prof. contact

+41564863506

leonhard.schaeffer@ksb.ch

Switzerland1 site, 1 recruiting
  • Kantonsspital Baden

    Baden, Canton of Aargau, 5400

    Amr S. Hamza, Assoc. Prof., +41564863513, amr.hamza@ksb.ch

    Leonhard Schaeffer, Prof., +41564863506, leonhard.schaeffer@ksb.ch

    Recruiting

Other trials in Switzerland

About this study

Official title: The Impact of Decidual Inclusion or Sparing in a Single Unlocked Closure of a Cesarean Uterine Incision: Randomized Controlled Trial

This study compares two ways of closing the uterus during cesarean delivery. In one group, the decidual layer near the uterine cavity is included in the suture. In the other group, this layer is left out. The study will examine whether these two methods differ in how well the uterine scar heals 6 to 9 months after surgery.

Women having an elective cesarean delivery will be randomly assigned to one of the two closure methods. Scar healing will be assessed by ultrasound after delivery. The goal is to determine whether one method is associated with better cesarean scar healing and fewer scar defects.

Read the detailed description

Cesarean scar defects, also referred to as niches or isthmoceles, are associated with gynecologic symptoms and adverse outcomes in subsequent pregnancies. The effect of uterine closure technique on scar healing remains uncertain, particularly with regard to whether the cavum-near decidual layer should be included in or excluded from the suture during cesarean closure.

This study is a prospective, randomized, controlled trial comparing two approaches to single-layer, non-locked uterine closure during elective cesarean delivery: decidual inclusion and decidual sparing. In both study groups, all operative steps are standardized except for the handling of the cavum-near decidual layer at the uterotomy margin.

Participants will be followed 6 to 9 months after cesarean delivery, including blinded ultrasound assessment of cesarean scar healing. The objective is to determine whether decidual inclusion or decidual sparing is associated with differences in postoperative uterine scar healing and cesarean scar defect formation.

Being tested
Single-Layered Non-Locked Closure with Decidual Inclusion, Single-Layered Non-Locked Closure with Decidual Sparing
Keywords
isthmocele, Uterine closure techniques, Decidual inclusion, Decidual sparing, Cesarean section, Scar thickness, Niche formation, Sonography, Dyspareunia
Medical subject headings
Dyspareunia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Single-Layered Non-Locked Closure with Decidual InclusionProcedure or surgery

    During the cesarean section, the uterine incision is closed with a single-layered, non-locked suture. In this technique, the decidua (the uterine lining) is included in the closure. This means that the endometrial cells are part of the suture, potentially influencing the healing process of the uterine scar.

    Goal: The idea is that including the decidua may promote better healing and scar formation, reducing the risk of complications such as isthmocele and improving long-term uterine health.

  • Single-Layered Non-Locked Closure with Decidual SparingProcedure or surgery

    Procedure: In this technique, the uterine incision is also closed using a single-layered non-locked suture, but the decidua is excluded from the closure. The suture is placed only through the myometrium (muscle layer) of the uterus, leaving the decidua out of the scar tissue.

    Goal: The intent is to observe if sparing the decidua results in better scar healing and a lower risk of isthmocele formation, as well as fewer long-term complications.

Study groups in NCT07608874
Study groupRoleWhat they receive
Decidual Inclusion ClosureExperimentalParticipants randomized to this arm will undergo elective cesarean delivery with single-layer, non-locked uterine closure in which the cavum-near decidual layer at the uterotomy margin is included in the suture. All other operative steps will be performed according to the standardized study protocol.
Receives: Procedure: Single-Layered Non-Locked Closure with Decidual Inclusion
Decidual Sparing ClosureExperimentalParticipants randomized to this arm will undergo elective cesarean delivery with single-layer, non-locked uterine closure in which the cavum-near decidual layer at the uterotomy margin is excluded from the suture. All other operative steps will be performed according to the standardized study protocol.
Receives: Procedure: Single-Layered Non-Locked Closure with Decidual Sparing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of participants with a cesarean scar niche measured by ultrasound

    Presence of a cesarean scar niche, defined as a myometrial indentation at the cesarean scar site with a depth of at least 2 mm, assessed by postoperative ultrasound. The outcome will be reported as the proportion of participants with a niche in each treatment group.

    Measured: 6 to 9 months post-operation

Secondary outcomes (17)
  1. Operative time

    Operative time in minutes

    Measured: Periprocedural

  2. Need for additional sutures for hemostasis

    Need for additional hemostatic sutures, yes (how many: __ Number) /no

    Measured: Periprocedural

  3. Length of hospital stay

    Length of postoperative hospital stay in days

    Measured: Postoperative day 2

  4. Postoperative pain intensity on the 11-point Numeric Rating Scale

    Pain intensity assessed using an 11-point Numeric Rating Scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate worse pain.

    Measured: Postoperative day 2

  5. Postoperative bleeding

    Clinically relevant postoperative bleeding, yes/no

    Measured: Postoperative day 2

  6. Wound infection

    Postoperative wound infection, yes/no

    Measured: Postoperative day 2

  7. Postoperative fever

    Postoperative fever, yes/no

    Measured: Postoperative day 2

  8. Abnormal uterine bleeding

    Abnormal uterine bleeding reported at follow-up, yes/no

    Measured: 6 to 9 months post-operation

  9. Dysmenorrhea

    Dysmenorrhea reported at follow-up, yes/no

    Measured: 6 to 9 months post-operation

  10. Chronic pelvic pain

    Chronic pelvic pain reported at follow-up, yes/no

    Measured: 6 to 9 months post-operation

  11. Dyspareunia

    Dyspareunia reported at follow-up, yes/no

    Measured: 6 to 9 months post-operation

  12. Cesarean scar niche length measured by ultrasound in mm

    Length of cesarean scar niche in mm measured by ultrasound.

    Measured: 6 to 9 months post-operation

  13. Cesarean scar niche depth measured by ultrasound in mm

    Depth of cesarean scar niche in mm measured by ultrasound.

    Measured: 6 to 9 months post-operation

  14. Cesarean scar niche width measured by ultrasound in mm

    Width of cesarean scar niche in mm measured by ultrasound.

    Measured: 6 to 9 months post-operation

  15. Residual myometrial thickness measured by ultrasound in mm

    Residual myometrial thickness measured by ultrasound in mm

    Measured: 6 to 9 months post-operation

  16. Presence of intrauterine fluid on ultrasound

    Presence or absence of intrauterine fluid on ultrasound.

    Measured: 6 to 9 months post-operation

  17. Residual-to-adjacent myometrial thickness ratio

    Ratio of residual myometrial thickness to adjacent myometrial thickness measured by ultrasound.

    Measured: 6 to 9 months post-operation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 May 2026
  2. Study start17 Jun 2026
  3. Primary completion1 May 2029 (estimated)
  4. Study completion30 May 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
374 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07608874
Sponsor's protocol ID
StudyKSBHAM001
Acronym
DISSUC
Status last verified
Aug 2026
First submitted
27 Aug 2025
Last updated
25 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: De-identified individual participant data will not be shared outside the research team because no external data-sharing process has been approved by the ethics committee or institution. Aggregate study results may be shared through publication or presentation.

Questions about this trial

What is this clinical trial studying?

A study testing Single-Layered Non-Locked Closure with Decidual Inclusion and Single-Layered Non-Locked Closure with Decidual Sparing in people with Isthmocele and Cesarean Scar Diverticula, run by Kantonsspital Baden at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 25 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Amr S. Hamza, Assoc. Prof. (+41564863513, amr.hamza@ksb.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of participants with a cesarean scar niche measured by ultrasound (time frame: 6 to 9 months post-operation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Aug 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in